BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2866986)

  • 1. The effects of long-acting injectable contraceptives on carbohydrate metabolism.
    Amatayakul K; Suriyanon V
    Int J Gynaecol Obstet; 1985 Oct; 23(5):361-8. PubMed ID: 2866986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Fahmy K; Abdel-Razik M; Shaaraway M; al-Kholy G; Saad S; Wagdi A; al-Azzony M
    Contraception; 1991 Oct; 44(4):419-30. PubMed ID: 1836754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
    Amatayakul K; Petpoo W; Ratanawananukul N; Tanthayaphinant O; Tovanabutra S; Suriyanon V
    Contraception; 1988 May; 37(5):483-92. PubMed ID: 2970367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception; 1982 Jan; 25(1):1-11. PubMed ID: 6460593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting hormonal contraceptives for women.
    Garza-Flores J; Hall PE; Perez-Palacios G
    J Steroid Biochem Mol Biol; 1991; 40(4-6):697-704. PubMed ID: 1958567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of injectable contraceptives in Assiut, Egypt.
    Salem HT; Salah M; Aly MY; Thabet AI; Shaaban MM; Fathalla MF
    Contraception; 1988 Dec; 38(6):697-710. PubMed ID: 2975583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
    Garza-Flores J; Alba VM; Cravioto MC; Hernandez L; Perez-Palacios G; Alvarado G; Rivera R; Recio R; Bassol S
    Contraception; 1989 May; 39(5):519-29. PubMed ID: 2524362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary response to LHRH in long-term users of injectable contraceptives.
    Ismail AA; el-Faras A; Rocca M; el-Sibai FA; Toppozada M
    Contraception; 1987 May; 35(5):487-95. PubMed ID: 2957167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of an injectable contraceptive: effect of depot-norethisterone oenanthate on carbohydrate metabolism.
    Griffin M; Heaton DA; McEwan JA
    Contraception; 1988 Jan; 37(1):53-60. PubMed ID: 3284711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Return of fertility in women discontinuing injectable contraceptives.
    Fotherby K; Howard G
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
    Andino N
    Contraception; 1981 Feb; 23(2):141-55. PubMed ID: 6786825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of two monthly injectable contraceptives and their effects on some metabolic parameters.
    Haiba NA; el-Habashy MA; Said SA; Darwish EA; Abdel-Sayed WS; Nayel SE
    Contraception; 1989 Jun; 39(6):619-32. PubMed ID: 2666019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Fraser IS
    Contraception; 1983 Oct; 28(4):385-97. PubMed ID: 6230212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Injectable contraception.
    Kaunitz AM
    Clin Obstet Gynecol; 1989 Jun; 32(2):356-68. PubMed ID: 2525977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolic studies in oophorectomised women: effects on serum lipids and lipoproteins of three synthetic progestogens.
    Silfverstolpe G; Gustafson A; Samsioe G; Svanborg A
    Maturitas; 1982 Aug; 4(2):103-11. PubMed ID: 6811837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Enk L; Landgren BM; Lindberg UB; Silfverstolpe G; Crona N
    Horm Metab Res; 1992 Feb; 24(2):85-9. PubMed ID: 1533383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women.
    Amatayakul K; Sivassomboon B; Singkamani R
    Contraception; 1980 Mar; 21(3):283-97. PubMed ID: 6446443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.